Spruce Biosciences (SPRB) Reiterated at Market Outperform by Citizens; 'Risk Mitigated'
Tweet Send to a Friend
Citizens analyst Jonathan Wolleben reiterated a Market Outperform rating and $170.00 price target on Spruce Biosciences, Inc. (NASDAQ: SPRB).The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
